2-205047664-G-A
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 0P and 2B. BP4_Moderate
The NM_001302769.2(PARD3B):c.478G>A(p.Gly160Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000209 in 1,550,400 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001302769.2 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000177 AC: 27AN: 152150Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.000214 AC: 33AN: 154258 AF XY: 0.000159 show subpopulations
GnomAD4 exome AF: 0.000212 AC: 297AN: 1398132Hom.: 0 Cov.: 30 AF XY: 0.000210 AC XY: 145AN XY: 689702 show subpopulations
GnomAD4 genome AF: 0.000177 AC: 27AN: 152268Hom.: 0 Cov.: 33 AF XY: 0.000215 AC XY: 16AN XY: 74440 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.478G>A (p.G160S) alteration is located in exon 4 (coding exon 4) of the PARD3B gene. This alteration results from a G to A substitution at nucleotide position 478, causing the glycine (G) at amino acid position 160 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at